3 questions to ask before accepting a penicillin allergy label
With 95% of low-risk patients labelled penicillin allergic tolerating the medicine on direct oral challenge, every penicillin allergy label should be questioned, Professor Jason Trubiano told the National Medicines Symposium today (11 November).
Strengthening interprofessional collaboration
At the heart of every health professional’s practice sits the goal of improving patient outcomes. To achieve this goal, interprofessional collaborative practice is fundamental to delivering effective, team-based, coordinated care for patients and healthcare consumers.
3 tips to build confidence in expanded scope of practice
As pharmacists take on greater responsibilities in primary care, international experience reveals a gap between being authorised to deliver new services and feeling confident enough to implement them in practice.
New GLP-1 RA weight-loss tablet approved in Australia
Australians prescribed semaglutide for weight management will soon have an alternative to weekly injections, after the Therapeutic Goods Administration (TGA) approved a once-daily tablet.
PSA appoints newest ECP Board Director
PSA welcomes the appointment of Lily Pham MPS as the Early Career Pharmacist (ECP) Director on the National Board.
POPULAR
3 questions to ask before accepting a penicillin allergy label
With 95% of low-risk patients labelled penicillin allergic tolerating the medicine on direct oral challenge, every penicillin allergy label should be questioned, Professor Jason Trubiano told the National Medicines Symposium today (11 November).
Strengthening interprofessional collaboration
At the heart of every health professional’s practice sits the goal of improving patient outcomes. To achieve this goal, interprofessional collaborative practice is fundamental to delivering effective, team-based, coordinated care for patients and healthcare consumers.
3 tips to build confidence in expanded scope of practice
As pharmacists take on greater responsibilities in primary care, international experience reveals a gap between being authorised to deliver new services and feeling confident enough to implement them in practice.
New GLP-1 RA weight-loss tablet approved in Australia
Australians prescribed semaglutide for weight management will soon have an alternative to weekly injections, after the Therapeutic Goods Administration (TGA) approved a once-daily tablet.
PSA appoints newest ECP Board Director
PSA welcomes the appointment of Lily Pham MPS as the Early Career Pharmacist (ECP) Director on the National Board.
POPULAR
A cup of tea, a Bex and a good lie down
Immortalised in Australian slang, the analgesic phenacetin (used in Bex powder) is wrapped up in the development of the modern pharmaceutical industry and has...
Pfizer COVID-19 vaccine health hubs announced
The Federal Government is calling on community pharmacists to help vaccinate millions of Australians against COVID-19.
Landmark Australian study on oxycodone prescribing
Oxycodone is the most prescribed strong opioid in Australia. Yet little was known about its use and prescribing patterns – until now.
Triptans downscheduled to S3 medicines
Last year, the Therapeutic Goods Administration announced that certain triptans will be available over the counter in 2021.
New CAL D instruction for antibiotics
A new cautionary advisory label for antibiotics that will replace decades of advice to take the medicines ‘until all used’ or ‘until all taken’ will be released next year.
Is Rikodeine still being rescheduled?
Last year, the TGA made an interim decision to reschedule Rikodeine to a prescription medicine. Why hasn’t it happened yet?
